Latest Breaking News On - Chris recknor - Page 3 : comparemela.com

Home / Top News / CytoDyn Receives First Purchase Order from Chiral Pharma Corporation for Use of Leronlimab Under CSP for COVID-19 Patients in the Philippines CytoDyn Receives First Purchase Order from Chiral Pharma Corporation for Use of Leronlimab Under CSP for COVID-19 Patients in the Philippines Chiral is simultaneously working on application for Emergency Use Authorization VANCOUVER, Washington, June 01, 2021 (GLOBE NEWSWIRE) CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing Vyrologix™ (leronlimab-Pro 140), a CCR5 antagonist with potential multiple therapeutic indications, announced today that Chiral Pharma Corporation in the Philippines placed its first purchase order for leronlimab under a Compassionate Special Permit (“CSP”) to treat critically ill COVID-19 patients in the Philippines. The Company expects to recognize revenues related to this purchase order upon fulfillment of the purchase order and

United statesBritish columbiaChris recknorExchange commissionHead of clinical development cytodynChiral pharma corporationDrug administrationCytodyn incEmergency useCompassionate special permitChief operating officerClinical developmentOne news philippinesAbout vyrologixCytodyn fast trackHuman immunodeficiency virus